Cargando…

Inflammation but Not Endothelial Dysfunction Is Associated with the Severity of Coronary Artery Disease in Dyslipidemic Subjects

Introduction. Endothelial dysfunction and inflammation play a key role in the development of atherosclerosis. The present study evaluated endothelial function, inflammatory parameters, and carotid intima-media thickness (IMT) in dyslipidemic patients with or without coronary artery disease (CAD). Me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rueda-Clausen, Christian F., López-Jaramillo, Patricio, Luengas, Carlos, Oubiña, Maria del Pilar, Cachofeiro, Victoria, Lahera, Vicente
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702507/ https://www.ncbi.nlm.nih.gov/pubmed/19584917 http://dx.doi.org/10.1155/2009/469169

Ejemplares similares

Aged Garlic Extract Improves Adiponectin Levels in Subjects with Metabolic Syndrome: A Double-Blind, Placebo-Controlled, Randomized, Crossover Study
por: Gómez-Arbeláez, Diego, et al.
Publicado: (2013)

A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
por: López-Jaramillo, Patricio, et al.
Publicado: (2006)

Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal
por: Rajamani, Anita, et al.
Publicado: (2019)

Cardiac Mitochondria Dysfunction in Dyslipidemic Mice
por: Braczko, Alicja, et al.
Publicado: (2022)

Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
por: Landi, Francesco, et al.
Publicado: (2019)

Improvement of antioxidant status after Brazil nut intake in hypertensive and dyslipidemic subjects
por: Huguenin, Grazielle V. B., et al.
Publicado: (2015)

Dyslipidemic drugs in metabolic syndrome
por: Siddiqi, Sheelu S., et al.
Publicado: (2013)

Serum lysophospholipid levels are altered in dyslipidemic hamsters
por: Suárez-García, Susana, et al.
Publicado: (2017)

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
por: Jäger, Bernhard, et al.
Publicado: (2018)

Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches
por: Medina-Leyte, Diana Jhoseline, et al.
Publicado: (2021)

Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
por: Reddy, G. Dilip, et al.
Publicado: (2012)

Potential benefits of L. acidophilus in dyslipidemic rats
por: Reamtong, Onrapak, et al.
Publicado: (2021)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

Coronary endothelial function testing may improve long-term quality of life in subjects with microvascular coronary endothelial dysfunction
por: Reriani, Martin, et al.
Publicado: (2019)

Aldosterone and Its Blockade: A Cardiovascular and Renal Perspective
por: Lahera, V., et al.
Publicado: (2006)

Is There a Link between Zinc Intake and Status with Plasma Fatty Acid Profile and Desaturase Activities in Dyslipidemic Subjects?
por: Knez, Marija, et al.
Publicado: (2019)

Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice
por: Puato, Massimo, et al.
Publicado: (2021)

The effect of dyslipidemic drugs on mortality: A meta-analysis
por: Jain, Shuchi, et al.
Publicado: (2009)

Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome
por: Lemche, A. V., et al.
Publicado: (2016)

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients
por: Kotani, Kazuhiko, et al.
Publicado: (2012)

Grape juice attenuates left ventricular hypertrophy in dyslipidemic mice
por: Martins, Ângela Maria, et al.
Publicado: (2020)

The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
por: Nartea, Roxana, et al.
Publicado: (2023)

Biomarkers as Surrogates for Coronary Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease
por: Vani, Anish, et al.
Publicado: (2018)

OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism
por: Perttilä, Julia, et al.
Publicado: (2009)

Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X
por: Long, Ming, et al.
Publicado: (2017)

Cholesterol-Induced Hepatic Inflammation Does Not Underlie the Predisposition to Insulin Resistance in Dyslipidemic Female LDL Receptor Knockout Mice
por: Gruben, Nanda, et al.
Publicado: (2015)

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
por: Hudson, Jaylen, et al.
Publicado: (2021)

Role of maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced
por: Cipriani, S, et al.
Publicado: (2012)

Effects of Astrocaryum aculeatum Meyer (Tucumã) on Diet-Induced Dyslipidemic Rats
por: Craveiro Holanda Malveira Maia, Geórgia, et al.
Publicado: (2014)

The use of probiotics for improving lipid profiles in dyslipidemic individuals: an overview protocol
por: Fortes, Patricia M., et al.
Publicado: (2018)

Effect of Flaxseed Powder on Cardiovascular Risk Factor in Dyslipidemic and Hypertensive Patients
por: Haghighatsiar, Naemeh, et al.
Publicado: (2019)

Inflammation in Coronary Microvascular Dysfunction
por: Sagris, Marios, et al.
Publicado: (2021)

Epicardial coronary spasm due to endothelial dysfunction after spontaneous coronary artery dissection
por: Stegehuis, V. E., et al.
Publicado: (2019)

Dyslipidemic Diet-Induced Monocyte “Priming” and Dysfunction in Non-Human Primates Is Triggered by Elevated Plasma Cholesterol and Accompanied by Altered Histone Acetylation
por: Short, John D., et al.
Publicado: (2017)

Endothelial microparticles and vascular parameters in subjects with and without arterial hypertension and coronary artery disease
por: Sansone, Roberto, et al.
Publicado: (2018)

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
por: Barakat, Lolwa, et al.
Publicado: (2013)

Comparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients
por: Bener, Abdulbari, et al.
Publicado: (2014)

Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia
por: Aleluia, Milena Magalhães, et al.
Publicado: (2017)

Association between Remnant-Like Particle Cholesterol and Gamma-Glutamyltransferase in Dyslipidemic Patients
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment
por: AYDIN, Kadriye, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rah5scamua6icq6qa788l7bljo